Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvalent (NUVL) Cash & Equivalents (2020 - 2026)

Nuvalent filings provide 7 years of Cash & Equivalents readings, the most recent being $159.7 million for Q1 2026.

  • Quarterly Cash & Equivalents rose 32.19% to $159.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $159.7 million through Mar 2026, up 32.19% year-over-year, with the annual reading at $261.7 million for FY2025, 79.66% up from the prior year.
  • Cash & Equivalents hit $159.7 million in Q1 2026 for Nuvalent, down from $261.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $369.2 million in Q3 2024 and bottomed at $67.3 million in Q1 2022.
  • Average Cash & Equivalents over 5 years is $148.4 million, with a median of $115.8 million recorded in 2025.
  • The largest annual shift saw Cash & Equivalents plummeted 68.96% in 2022 before it soared 317.54% in 2024.
  • Nuvalent's Cash & Equivalents stood at $241.8 million in 2022, then soared by 38.7% to $335.4 million in 2023, then plummeted by 56.56% to $145.7 million in 2024, then soared by 79.66% to $261.7 million in 2025, then tumbled by 38.97% to $159.7 million in 2026.
  • Per Business Quant, the three most recent readings for NUVL's Cash & Equivalents are $159.7 million (Q1 2026), $261.7 million (Q4 2025), and $115.8 million (Q3 2025).